Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.

Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, Wong DF, Pontecorvo MJ, Mintun MA, Devous MD Sr.

Alzheimers Dement. 2018 Jul 10. pii: S1552-5260(18)31525-5. doi: 10.1016/j.jalz.2018.06.1353. [Epub ahead of print]

PMID:
30006100
2.

Topographic staging of tau positron emission tomography images.

Schwarz AJ, Shcherbinin S, Slieker LJ, Risacher SL, Charil A, Irizarry MC, Fleisher AS, Southekal S, Joshi AD, Devous MD Sr, Miller BB, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement (Amst). 2018 Feb 14;10:221-231. doi: 10.1016/j.dadm.2018.01.006. eCollection 2018.

3.

Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.

Devous MD Sr, Joshi AD, Navitsky M, Southekal S, Pontecorvo MJ, Shen H, Lu M, Shankle WR, Seibyl JP, Marek K, Mintun MA.

J Nucl Med. 2018 Jun;59(6):937-943. doi: 10.2967/jnumed.117.200691. Epub 2017 Dec 28.

PMID:
29284675
4.

Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity.

Southekal S, Devous MD Sr, Kennedy I, Navitsky M, Lu M, Joshi AD, Pontecorvo MJ, Mintun MA.

J Nucl Med. 2018 Jun;59(6):944-951. doi: 10.2967/jnumed.117.200006. Epub 2017 Nov 30.

PMID:
29191858
5.

Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.

Sheng M, Lu H, Liu P, Li Y, Ravi H, Peng SL, Diaz-Arrastia R, Devous MD, Womack KB.

J Alzheimers Dis. 2017;60(4):1351-1364. doi: 10.3233/JAD-161006.

6.

18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.

Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD.

Ann Neurol. 2017 Oct;82(4):622-634. doi: 10.1002/ana.25060.

7.

Effectiveness of Florbetapir PET Imaging in Changing Patient Management.

Pontecorvo MJ, Siderowf A, Dubois B, Doraiswamy PM, Frisoni GB, Grundman M, Nobili F, Sadowsky CH, Salloway S, Arora AK, Chevrette A, Deberdt W, Dell'Agnello G, Flitter M, Galante N, Lowrey MJ, Lu M, McGeehan A, Devous MD Sr, Mintun MA.

Dement Geriatr Cogn Disord. 2017;44(3-4):129-143. doi: 10.1159/000478007. Epub 2017 Aug 5.

8.

Correlation between two methods of florbetapir PET quantitative analysis.

Breault C, Piper J, Joshi AD, Pirozzi SD, Nelson AS, Lu M, Pontecorvo MJ, Mintun MA, Devous MD.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):84-91. eCollection 2017.

9.

Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.

Farrell ME, Kennedy KM, Rodrigue KM, Wig G, Bischof GN, Rieck JR, Chen X, Festini SB, Devous MD Sr, Park DC.

JAMA Neurol. 2017 Jul 1;74(7):830-838. doi: 10.1001/jamaneurol.2017.0892.

10.

Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials.

Fleisher AS, Joshi AD, Sundell KL, Chen YF, Kollack-Walker S, Lu M, Chen S, Devous MD Sr, Seibyl J, Marek K, Siemers ER, Mintun MA.

Alzheimers Dement. 2017 Oct;13(10):1117-1124. doi: 10.1016/j.jalz.2017.02.009. Epub 2017 Mar 30.

PMID:
28365320
11.

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA; 18F-AV-1451-A05 investigators.

Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.

12.

Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.

Pontecorvo MJ, Arora AK, Devine M, Lu M, Galante N, Siderowf A, Devadanam C, Joshi AD, Heun SL, Teske BF, Truocchio SP, Krautkramer M, Devous MD Sr, Mintun MA.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):825-837. doi: 10.1007/s00259-016-3601-4. Epub 2017 Jan 7.

PMID:
28064343
13.

Amyloid deposition in younger adults is linked to episodic memory performance.

Bischof GN, Rodrigue KM, Kennedy KM, Devous MD Sr, Park DC.

Neurology. 2016 Dec 13;87(24):2562-2566. Epub 2016 Nov 11.

14.

Successful classification of cocaine dependence using brain imaging: a generalizable machine learning approach.

Mete M, Sakoglu U, Spence JS, Devous MD Sr, Harris TS, Adinoff B.

BMC Bioinformatics. 2016 Oct 6;17(Suppl 13):357.

15.

Revolutionizing Alzheimer's disease and clinical trials through biomarkers.

Mattsson N, Carrillo MC, Dean RA, Devous MD Sr, Nikolcheva T, Pesini P, Salter H, Potter WZ, Sperling RS, Bateman RJ, Bain LJ, Liu E.

Alzheimers Dement (Amst). 2015 Oct 3;1(4):412-9. doi: 10.1016/j.dadm.2015.09.001. eCollection 2015 Dec. Review.

16.

Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease.

Shcherbinin S, Schwarz AJ, Joshi A, Navitsky M, Flitter M, Shankle WR, Devous MD Sr, Mintun MA.

J Nucl Med. 2016 Oct;57(10):1535-1542. Epub 2016 May 5.

17.

Dopamine efflux in response to ultraviolet radiation in addicted sunbed users.

Aubert PM, Seibyl JP, Price JL, Harris TS, Filbey FM, Jacobe H, Devous MD Sr, Adinoff B.

Psychiatry Res Neuroimaging. 2016 May 30;251:7-14. doi: 10.1016/j.pscychresns.2016.04.001. Epub 2016 Apr 7.

18.

Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M, Joshi AD, Devous MD Sr, Mintun MS.

Brain. 2016 May;139(Pt 5):1539-50. doi: 10.1093/brain/aww023. Epub 2016 Mar 2.

PMID:
26936940
19.

Bridging the Gap between Research and Clinical Practice in Asymptomatic Alzheimer's Disease.

Downing AM, Yaari R, Ball DE, Selzler KJ, Devous MD Sr.

J Prev Alzheimers Dis. 2016;3(1):30-42. doi: 10.14283/jpad.2015.86.

PMID:
29214279
20.

A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.

Joshi AD, Pontecorvo MJ, Lu M, Skovronsky DM, Mintun MA, Devous MD Sr.

J Nucl Med. 2015 Nov;56(11):1736-41. doi: 10.2967/jnumed.114.153494. Epub 2015 Sep 3.

21.

Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir.

Trembath L, Newell M, Devous MD Sr.

J Nucl Med Technol. 2015 Sep;43(3):175-84. doi: 10.2967/jnmt.115.156679. Epub 2015 Aug 13. Review.

22.

The effect of beta-amyloid on face processing in young and old adults: A multivariate analysis of the BOLD signal.

Rieck JR, Rodrigue KM, Kennedy KM, Devous MD Sr, Park DC.

Hum Brain Mapp. 2015 Jul;36(7):2514-26. doi: 10.1002/hbm.22788. Epub 2015 Apr 2.

23.

Quantification of 18F-florbetapir PET: comparison of two analysis methods.

Hutton C, Declerck J, Mintun MA, Pontecorvo MJ, Devous MD Sr, Joshi AD; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):725-32. doi: 10.1007/s00259-015-2988-7. Epub 2015 Feb 5.

PMID:
25652817
24.

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.

Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA.

Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4. doi: 10.1016/j.jalz.2014.07.003. Epub 2014 Oct 28.

25.

Interaction between early life stress and alcohol dependence on neural stress reactivity.

Yang H, Spence JS, Briggs RW, Rao U, North C, Devous MD Sr, Xiao H, Adinoff B.

Addict Biol. 2015 May;20(3):523-33. doi: 10.1111/adb.12135. Epub 2014 Mar 7.

26.

Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals.

McHugh MJ, Demers CH, Salmeron BJ, Devous MD Sr, Stein EA, Adinoff B.

Front Psychiatry. 2014 Feb 27;5:16. doi: 10.3389/fpsyt.2014.00016. eCollection 2014.

27.

Altered neural processing of threat in alcohol-dependent men.

Yang H, Devous MD, Briggs RW, Spence JS, Xiao H, Kreyling N, Adinoff B.

Alcohol Clin Exp Res. 2013 Dec;37(12):2029-38. doi: 10.1111/acer.12187. Epub 2013 Jul 24.

28.

Risk factors for mild cognitive impairment among Mexican Americans.

O'Bryant SE, Johnson L, Reisch J, Edwards M, Hall J, Barber R, Devous MD Sr, Royall D, Singh M.

Alzheimers Dement. 2013 Nov;9(6):622-631.e1. doi: 10.1016/j.jalz.2012.12.007. Epub 2013 May 2.

29.

Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.

Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC.

JAMA Neurol. 2013 May;70(5):600-6. doi: 10.1001/jamaneurol.2013.1342.

30.

The link between C-reactive protein and Alzheimer's disease among Mexican Americans.

O'Bryant SE, Johnson L, Edwards M, Soares H, Devous MD, Ross S, Rohlfing G, Hall J; Texas Alzheimer’s Research & Care Consortium.

J Alzheimers Dis. 2013;34(3):701-6. doi: 10.3233/JAD-122071.

31.

Striatal-limbic activation is associated with intensity of anticipatory anxiety.

Yang H, Spence JS, Devous MD Sr, Briggs RW, Goyal A, Xiao H, Yadav H, Adinoff B.

Psychiatry Res. 2012 Nov 30;204(2-3):123-31. doi: 10.1016/j.pscychresns.2012.10.001. Epub 2012 Nov 6.

32.
33.

Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan.

Kennedy KM, Rodrigue KM, Devous MD Sr, Hebrank AC, Bischof GN, Park DC.

Neuroimage. 2012 Aug 1;62(1):1-8. doi: 10.1016/j.neuroimage.2012.03.077. Epub 2012 May 1.

34.

Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects.

Adinoff B, Devous MD, Williams MJ, Harris TS, Best SE, Dong H, Zielinski T.

Addict Biol. 2014 Mar;19(2):250-61. doi: 10.1111/j.1369-1600.2012.00450.x. Epub 2012 Mar 28.

35.

β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.

Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, Mathews D, Park DC.

Neurology. 2012 Feb 7;78(6):387-95. doi: 10.1212/WNL.0b013e318245d295. Epub 2012 Feb 1.

36.

A comprehensive reliability assessment of quantitative diffusion tensor tractography.

Wang JY, Abdi H, Bakhadirov K, Diaz-Arrastia R, Devous MD Sr.

Neuroimage. 2012 Apr 2;60(2):1127-38. doi: 10.1016/j.neuroimage.2011.12.062. Epub 2011 Dec 29.

37.

Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography.

Liu P, Uh J, Devous MD, Adinoff B, Lu H.

NMR Biomed. 2012 May;25(5):779-86. doi: 10.1002/nbm.1792. Epub 2011 Dec 2.

38.

Caudolateral orbitofrontal regional cerebral blood flow is decreased in abstinent cocaine-addicted subjects in two separate cohorts.

Adinoff B, Braud J, Devous MD, Harris TS.

Addict Biol. 2012 Nov;17(6):1001-12. doi: 10.1111/j.1369-1600.2011.00414.x. Epub 2011 Nov 29.

39.

Longitudinal changes of structural connectivity in traumatic axonal injury.

Wang JY, Bakhadirov K, Abdi H, Devous MD Sr, Marquez de la Plata CD, Moore C, Madden CJ, Diaz-Arrastia R.

Neurology. 2011 Aug 30;77(9):818-26. doi: 10.1212/WNL.0b013e31822c61d7. Epub 2011 Aug 3.

40.

Activation of the mesostriatal reward pathway with exposure to ultraviolet radiation (UVR) vs. sham UVR in frequent tanners: a pilot study.

Harrington CR, Beswick TC, Graves M, Jacobe HT, Harris TS, Kourosh S, Devous MD Sr, Adinoff B.

Addict Biol. 2012 May;17(3):680-6. doi: 10.1111/j.1369-1600.2010.00312.x. Epub 2011 Apr 11.

PMID:
21481104
41.

Deficits in functional connectivity of hippocampal and frontal lobe circuits after traumatic axonal injury.

Marquez de la Plata CD, Garces J, Shokri Kojori E, Grinnan J, Krishnan K, Pidikiti R, Spence J, Devous MD Sr, Moore C, McColl R, Madden C, Diaz-Arrastia R.

Arch Neurol. 2011 Jan;68(1):74-84. doi: 10.1001/archneurol.2010.342.

42.

Diffusion tensor imaging biomarkers for traumatic axonal injury: analysis of three analytic methods.

Marquez de la Plata CD, Yang FG, Wang JY, Krishnan K, Bakhadirov K, Paliotta C, Aslan S, Devous MD, Moore C, Harper C, McColl R, Munro Cullum C, Diaz-Arrastia R.

J Int Neuropsychol Soc. 2011 Jan;17(1):24-35. doi: 10.1017/S1355617710001189. Epub 2010 Nov 12.

43.

Altered neural cholinergic receptor systems in cocaine-addicted subjects.

Adinoff B, Devous MD Sr, Williams MJ, Best SE, Harris TS, Minhajuddin A, Zielinski T, Cullum M.

Neuropsychopharmacology. 2010 Jun;35(7):1485-99. doi: 10.1038/npp.2010.18. Epub 2010 Mar 10.

44.

Procedure guideline for brain perfusion SPECT using (99m)Tc radiopharmaceuticals 3.0.

Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, Carretta RF, Chen CC; Society for Nuclear Medicine.

J Nucl Med Technol. 2009 Sep;37(3):191-5. doi: 10.2967/jnmt.109.067850. Epub 2009 Aug 19. No abstract available.

45.

Neural response to lidocaine in healthy subjects.

Adinoff B, Devous MD Sr, Cooper DC, Best SE, Harris TS, Williams MJ.

Psychiatry Res. 2009 Aug 30;173(2):135-42. doi: 10.1016/j.pscychresns.2009.03.001. Epub 2009 Jun 28.

46.

Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War.

Haley RW, Spence JS, Carmack PS, Gunst RF, Schucany WR, Petty F, Devous MD Sr, Bonte FJ, Trivedi MH.

Psychiatry Res. 2009 Mar 31;171(3):207-20. doi: 10.1016/j.pscychresns.2008.05.004. Epub 2009 Feb 20.

PMID:
19230625
47.

Cerebral atrophy after traumatic white matter injury: correlation with acute neuroimaging and outcome.

Ding K, Marquez de la Plata C, Wang JY, Mumphrey M, Moore C, Harper C, Madden CJ, McColl R, Whittemore A, Devous MD, Diaz-Arrastia R.

J Neurotrauma. 2008 Dec;25(12):1433-40. doi: 10.1089/neu.2008.0683.

48.

Diffusion tensor tractography of traumatic diffuse axonal injury.

Wang JY, Bakhadirov K, Devous MD Sr, Abdi H, McColl R, Moore C, Marquez de la Plata CD, Ding K, Whittemore A, Babcock E, Rickbeil T, Dobervich J, Kroll D, Dao B, Mohindra N, Madden CJ, Diaz-Arrastia R.

Arch Neurol. 2008 May;65(5):619-26. doi: 10.1001/archneur.65.5.619.

PMID:
18474737
49.

A SPECT study of language and brain reorganization three years after pediatric brain injury.

Chiu Wong SB, Chapman SB, Cook LG, Anand R, Gamino JF, Devous MD Sr.

Prog Brain Res. 2006;157:173-185.

PMID:
17167907
50.

A picture is worth.

Devous MD Sr.

Exp Biol Med (Maywood). 2006 Dec;231(11):1679. No abstract available.

PMID:
17138751

Supplemental Content

Loading ...
Support Center